Publication date: Available online 25 October 2026 Source: Annals of Oncology Author(s): Andrea Cercek, Jean-Baptiste Bachet, Gunnar Folprecht, Hideaki Bando, Jenny Seligmann, Naureen Starling, Maria Carmen Riesco-Martinez, Pilar Garcia Alfonso, Denis Smith, Lisa Salvatore, Encarna Gonzalez Flores, Emmanuel Mitry, Eric Chen, Jaume Capdevila Castillon, Federica Morano, Susana Roselló Keränen, Francine Aubin, Carlos López López, Sara Lonardi, Gary Buchschacher
Clinical Complete Response with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer: First Results from the Global AZUR-1 Trial. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426080701?dgcid=rss_sd_all
Clinical Complete Response with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer: First Results from the Global AZUR-1 Trial. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426080701?dgcid=rss_sd_all
“Clinical Complete Response with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer: First Results from the Global AZUR-1 Trial.” Annals of Oncology.
@article{article36155,
title = {Clinical Complete Response with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer: First Results from the Global AZUR-1 Trial},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426080701?dgcid=rss_sd_all}
}